SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
8.80    0.50 (6.02%)
Bid:
8.80
Ask:
9.00
Spread: 0.20 (2.273%)
Market Cap: $941.94m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

Equity Offering by Controlling Shareholder

7 Dec 2010 16:15

RNS Number : 5398X
MHP S.A.
07 December 2010
 



THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE RUSSIAN FEDERATION, UKRAINE, THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

07 December 2010

MHP S.A.

 

Announces Equity Offering by Controlling Shareholder

 

MHP S.A. ("MHP" or the "Company", LSE ticker: "MHPC"), one of the leading agro-industrial companies in Ukraine, focusing on the production of poultry and the cultivation of grain, today announces that WTI Trading Limited (the "Selling Shareholder") is offering up to approximately 10% of the Company's ordinary shares in the form of Global Depositary Receipts ("GDRs"), including an overallotment option, with one GDR representing an interest in one share (the "Offering").

 

The Selling Shareholder, a limited liability company organised under the laws of Cyprus, is beneficially owned by Yuriy Kosiuk, the controlling beneficial shareholder and CEO of the Company.

 

The Offering includes an over-allotment option, granted by the Selling Shareholder to the joint bookrunners, to acquire additional GDRs representing up to 15% of the number of GDRs initially placed, exercisable within 30 days of announcement of the offer price.

 

The Company and the Selling Shareholder have agreed, subject to customary exceptions, to enter into a lock-up agreement for a period of 180 days following completion of the Offering.

 

The GDRs to be issued in the Offering will be listed on the London Stock Exchange pursuant to the Company's existing block listing of GDRs.

 

Morgan Stanley and UBS Investment Bank are acting as Joint Bookrunners for the Offering.

 

 

ENQUIRIES

MHP Investor Relations

Anastasiia Sobotiuk Kyiv: +38 044 207 99 58

 

Financial Dynamics

Ben Foster (London)

Marc Cohen (London)

Leonid Solovyev (Moscow)

 

 

London: +44 20 7831 3113

 

Moscow: +7 495 795 06 23

 

 

 

Important Notice

Morgan Stanley & Co International plc and UBS Limited, each of which is authorised and regulated in the UK by the Financial Services Authority, are acting exclusively for the Company and, in respect of only of the sale of GDRs, the Selling Shareholder and no one else in connection with the Offering and will not regard any other person (whether or not a recipient of this announcement) as their respective clients and will not be responsible to anyone other than the Company and the Selling Shareholder for providing the protections afforded to clients of Morgan Stanley & Co. International plc and UBS Limited nor for giving advice in relation to the Offering, the contents of this announcement or any transaction or arrangement referred to herein.

 

The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United Kingdom or any other European Economic Area state, Australia, Canada, Japan, Ukraine, the Russian Federation, or the United States. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada, Japan, Ukraine or the Russian Federation or any other jurisdiction. There will be no public offer of the securities in the United States or elsewhere.

 

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom (subject to applicable laws), (ii) to investment professionals falling within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (iii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents. Persons distributing this document must satisfy themselves that it is lawful to do so.

 

In connection with the offering, Morgan Stanley & Co. International plc (the "Stabilizing Manager") (or persons acting on behalf of the Stabilizing Manager) may (but is under no obligation to) effect transactions in the GDRs with a view to supporting the market price of the GDRs at a level higher than that which might otherwise have prevailed in the open market. However, there is no assurance that the Stabilizing Manager (or persons acting on behalf of the Stabilizing Manager) will undertake stabilization action. Any stabilization action may begin on or after the date on which adequate public disclosure of the final price of the global depositary receipts is made and, if begun, may be ended at any time, but it must end no later than 30 days after the date of such adequate public disclosure of the final price of the GDRs. Any stabilization action must be conducted by the Stabilizing Manager (or person(s) acting on behalf of the Stabilizing Manager) in accordance with all applicable laws and rules. Save as required by law or regulation, neither the Stabilizing Manager nor any of its agents intends to disclose the extent of any stabilization transactions conducted in relation to the Offering.

 

This document is an advertisement and is not a prospectus for the purposes of EU Directive 2003/71/EC (the "Prospectus Directive") and Part VI of the Financial Services and Markets Act 2000 (the "FSMA"). In any EEA Member State that has implemented the Prospectus Directive this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.

 

In connection with the Offering, Morgan Stanley & Co. International plc or UBS Limited, or any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase GDRs and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such GDRs and other securities of the Company or related investments in connection with the Offering or otherwise. Accordingly, references to the GDRs being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Morgan Stanley & Co. International plc or UBS Limited or any of their respective affiliates acting as investors for their own accounts. Morgan Stanley & Co. International plc and UBS Limited do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

 

The offer and the distribution of this press release and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

 

This announcement and information contained therein are for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. Information in this announcement cannot be relied upon as a guide to future performance. The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISTRBFTMBBMBTM
Date   Source Headline
9th Sep 20217:32 amRNSFinancial Results for H1 and Q2 2021 (2 part)
9th Sep 20217:32 amRNSFinancial Results for H1 and Q2 2021
23rd Aug 202110:30 amRNSDate notification
16th Jul 20219:15 amRNSPre-Close TU for the Q2 and 6M 2021
30th Jun 202111:03 amRNSMHP today releases Non-Financial Report 2020
19th May 20217:03 amRNSFinancial Results for the Q1 2021
11th May 202111:46 amRNSDate Notification
28th Apr 202112:02 pmRNSDistribution of Dividends
28th Apr 202111:44 amRNSMinutes of 2021 AGM
21st Apr 202112:40 pmRNSMerger of MHP SE with Raftan, Hemiak and Eledem
16th Apr 20219:20 amRNSPre-close TU for the Q1 2021 corrected version
15th Apr 20217:03 amRNSPre-close trading update for the Q1 2021
29th Mar 20219:54 amRNSAGM Date Change Notification
24th Mar 202111:37 amRNSFinancial results for the Q4 and 12M 2020
24th Mar 20218:35 amRNSSeparate Financial Statements
24th Mar 20218:11 amRNSAnnual Report 2020 Full version
24th Mar 20217:00 amRNSFinancial results for the Q4 and 12M 2020
18th Mar 20212:41 pmRNSMerger of MHP SE with Raftan, Hemiak and Eledem
15th Mar 20217:28 amRNSDate Notification
15th Feb 20211:08 pmRNSNotice of Extraordinary General Meeting
15th Feb 202111:42 amRNSMerger of MHP SE
9th Feb 20212:33 pmRNSRetirement of director
28th Jan 20217:00 amRNSPre-close trading update for the Q4 and 12M 2020
19th Jan 20212:06 pmRNSBoard Changes
23rd Nov 20204:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:35 pmRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSFinancial Results for the Q3 and 9M 2020
13th Nov 20207:07 amRNSDate Notification
21st Oct 20207:09 amRNSPre-close TU for the Q3 and 9M 2020
4th Sep 20207:00 amRNSQ2 and H1 2020 Financial Results
26th Aug 20209:28 amRNSQ1 and H1 2020 Date Notification
24th Aug 202012:08 pmRNSSecond Price Monitoring Extn
24th Aug 202012:03 pmRNSPrice Monitoring Extension
20th Aug 20204:41 pmRNSSecond Price Monitoring Extn
20th Aug 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:22 amRNSPre-Close TU for the Q2 and six months 2020
2nd Jul 20204:35 pmRNSPrice Monitoring Extension
30th Jun 20202:12 pmRNSNon-Financial Report 2019
18th Jun 20201:17 pmRNSResults of AGM
2nd Jun 20207:08 amRNS1st Quarter Results
26th May 20207:00 amRNSDate Notification
15th May 20208:10 amRNSNotice of Annual General Meeting
14th May 20203:28 pmRNSNotification about threshold crossing in MHP’sGDRs
23rd Apr 20207:02 amRNSPre-close trading update for the Q1 2020
16th Apr 20207:00 amRNSDistribution of Dividends
14th Apr 202010:49 amRNSAnnual Financial Report 2019
14th Apr 20208:58 amRNSMHP SE Standalone Financial Statements 2019
14th Apr 20207:07 amRNSMHP SE Financial Statements 2019
3rd Apr 202012:23 pmRNSDate Notification - DATE RESCHEDULED
25th Mar 202010:55 amRNSResults of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.